Unlike clinical-grade stimulators that require medical supervision or invasive procedures, Pulsetto is positioned within the ...

On July 30, the FDA approved the first device of its kind — a vagal nerve stimulator for adults with moderate to severe ...

Ultrasound stimulation represents a rapidly evolving field that harnesses acoustic energy to non-invasively modulate neural circuitry. This approach offers exceptional spatial resolution and depth ...

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...

NEWTOWN, Pa., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation ...

- This demonstration of a miniature implantable stimulator used in humans could unlock minimally invasive therapies for treatment-resistant neuropsychiatric disorders - Approximately 30% of adults ...

NEWTOWN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...

This strategically assembled SAB will provide scientific, clinical, regulatory, and commercial guidance as Sinaptica prepares for its pivotal clinical trial in Alzheimer’s disease and advances ...

New precision neuromodulation techniques are redefining what's possible for neurological recovery, and the National ...

Helius Medical Technologies Inc (NASDAQ:HSDT) shares are trading higher after the Centers for Medicare & Medicaid Services assigned Healthcare Common Procedure Coding System (HCPCS) Level II codes ...